82 related articles for article (PubMed ID: 11836607)
1. Uptake of indium-111-labeled human polyclonal immunoglobulin G in pancreatic cancer: in vivo and in vitro studies.
Karanikas G; Ulrich-Pur H; Becherer A; Wiesner K; Dudczak R; Raderer M; Kletter K
Oncol Rep; 2002; 9(2):353-7. PubMed ID: 11836607
[TBL] [Abstract][Full Text] [Related]
2. Iodine-123-vasoactive intestinal peptide receptor scanning in patients with pancreatic cancer.
Raderer M; Kurtaran A; Yang Q; Meghdadi S; Vorbeck F; Hejna M; Angelberger P; Kornek G; Pidlich J; Scheithauer W; Virgolini I
J Nucl Med; 1998 Sep; 39(9):1570-5. PubMed ID: 9744345
[TBL] [Abstract][Full Text] [Related]
3. Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy.
Raderer M; Becherer A; Kurtaran A; Angelberger P; Li S; Leimer M; Weinlaender G; Kornek G; Kletter K; Scheithauer W; Virgolini I
J Nucl Med; 1996 Sep; 37(9):1480-7. PubMed ID: 8790198
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
[TBL] [Abstract][Full Text] [Related]
5. Preoperative clinical radioimmunodetection of pancreatic cancer by 111 In-labeled chimeric monoclonal antibody Nd2.
Sawada T; Nishihara T; Yamamoto A; Teraoka H; Yamashita Y; Okamura T; Ochi H; Ho JJ; Kim YS; Hirakawa K
Jpn J Cancer Res; 1999 Oct; 90(10):1179-86. PubMed ID: 10595748
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.
Schima W; Függer R; Schober E; Oettl C; Wamser P; Grabenwöger F; Ryan JM; Novacek G
AJR Am J Roentgenol; 2002 Sep; 179(3):717-24. PubMed ID: 12185052
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-HMPAO-labeled leukocytes and technetium-99m-labeled human polyclonal immunoglobulin G in diagnosis of focal purulent disease.
Hovi I; Taavitsainen M; Lantto T; Vorne M; Paul R; Remes K
J Nucl Med; 1993 Sep; 34(9):1428-34. PubMed ID: 8355059
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.
Barbet J; Peltier P; Bardet S; Vuillez JP; Bachelot I; Denet S; Olivier P; Leccia F; Corcuff B; Huglo D; Proye C; Rouvier E; Meyer P; Chatal JF
J Nucl Med; 1998 Jul; 39(7):1172-8. PubMed ID: 9669389
[TBL] [Abstract][Full Text] [Related]
9. Tc-99m-labeled nonspecific polyclonal human immunoglobulin G is taken up by malignant tumors.
Arka A; Aktolun C; Gooden C; Epenetos A; Papadimitriou A
Clin Nucl Med; 1994 Aug; 19(8):708-12. PubMed ID: 7955752
[TBL] [Abstract][Full Text] [Related]
10. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer: value of dual-phase helical CT in assessing resectability.
Diehl SJ; Lehmann KJ; Sadick M; Lachmann R; Georgi M
Radiology; 1998 Feb; 206(2):373-8. PubMed ID: 9457188
[TBL] [Abstract][Full Text] [Related]
12. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
Delbeke D; Rose DM; Chapman WC; Pinson CW; Wright JK; Beauchamp RD; Shyr Y; Leach SD
J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771
[TBL] [Abstract][Full Text] [Related]
13. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
[TBL] [Abstract][Full Text] [Related]
14. Lesion-by-lesion comparison of computerized tomography and indium-111-labeled monoclonal antibody C110 radioimmunoscintigraphy in colorectal carcinoma: a multicenter trial.
Divgi CR; McDermott K; Griffin TW; Johnson DK; Schnobrich KE; Fallone PS; Scott AM; Hilton S; Cohen AM; Larson SM
J Nucl Med; 1993 Oct; 34(10):1656-61. PubMed ID: 8410278
[TBL] [Abstract][Full Text] [Related]
15. [Value of dual-phase-helical CT in the preoperative diagnosis of pancreatic cancer--a prospective study].
Lehmann KJ; Diehl SJ; Lachmann R; Georgi M
Rofo; 1998 Mar; 168(3):211-6. PubMed ID: 9551105
[TBL] [Abstract][Full Text] [Related]
16. 111In-pentetreotide (somatostatin analogue) scintigraphy as an imaging procedure for endocrine gastro-entero-pancreatic tumors.
Nauck C; Ivancević V; Emrich D; Creutzfeldt W
Z Gastroenterol; 1994 Jun; 32(6):323-7. PubMed ID: 7975760
[TBL] [Abstract][Full Text] [Related]
17. [Indium-111-DTPA-phenyl-pentetreotide somatostatin receptors' scintigraphy in the evaluation of patients with suspected gastro-entero-pancreatic tumors. Comparison with computerized tomography].
Gerasimou GP; Aggelopoulou T; Papanastasiou E; Konidari-Dedousi E; Prousalidis I; Psarrakos K; Siountas A; Molybda E; Gotzamani-Psarrakou A
Hell J Nucl Med; 2007; 10(3):209-14. PubMed ID: 18084669
[TBL] [Abstract][Full Text] [Related]
18. Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery.
Valls C; Andía E; Sanchez A; Fabregat J; Pozuelo O; Quintero JC; Serrano T; Garcia-Borobia F; Jorba R
AJR Am J Roentgenol; 2002 Apr; 178(4):821-6. PubMed ID: 11906855
[TBL] [Abstract][Full Text] [Related]
19. [Assessment of 18FDG PET for diagnosis of pancreatic tumors].
Granov AM; Tiutin LA; Ryzhkova DV; Kostenikov NA; Fadeev NP; Savello VE; Pavlovskiĭ AV; Tlostanova MS; Efimenko AV; Stanzhevskiĭ AA
Vestn Rentgenol Radiol; 2002; (2):18-22. PubMed ID: 12216484
[TBL] [Abstract][Full Text] [Related]
20. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
